| Authors: |
Gort J; Department of Epidemiology & Health Economics, Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, The Netherlands., van Hattem CC; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Logman F; Department for High-Cost Medicines, Menzis, Healthcare Insurance Company, Wageningen, The Netherlands., Frederix GWJ; Department of Epidemiology & Health Economics, Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, The Netherlands., Hooft L; Department of Epidemiology & Health Economics, Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, The Netherlands.; Cochrane Netherlands, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands., Bloem LT; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Ten Ham RMT; Department of Epidemiology & Health Economics, Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, The Netherlands.; Innovation Center for Advanced Therapies (ICAT), University Medical Centre Utrecht, Utrecht, The Netherlands. |